-
2 weeks ago | 
thebluntness.com | Harrison Wise |Shryne Group |Hemptown USA
New York’s legal cannabis program is once again under the microscope—and this time, the stakes are higher than ever. According to a recent report in The New York Times by Ashley Southall (April 7, 2025 article), multiple cannabis businesses across the state are being scrutinized for alleged violations, irregularities, and potential misconduct tied to licensing, operations, and state oversight.
-
3 weeks ago | 
thebluntness.com | Harrison Wise
When California-based Gold Flora entered the legal cannabis scene, the company was poised to dominate. Backed by serious money and a sprawling, vertically integrated operation—from a 100,000-square-foot cultivation campus in the desert to marquee dispensaries in West Hollywood and San Jose—Gold Flora wasn't just riding the green wave. It was supposed to be the wave. But by the end of March 2025, the company had filed for receivership, its assets now headed to auction.
-
3 weeks ago | 
thebluntness.com | Harrison Wise |Shryne Group |Hemptown USA |Taylor Engle
SXSW 2025, held from March 7 to 15 in Austin, Texas, prominently featured a Psychedelics Track, highlighting the expanding role of psychoactive substances in culture, medicine, and policy. The Psychedelics Track offered a diverse array of sessions aimed at broadening the understanding of psychoactive substances. Researchers, healthcare professionals, and investors gathered to discuss efforts to dissolve stigma and reshape perceptions of psychedelics.
-
Nov 22, 2024 | 
thebluntness.com | Harrison Wise |Shryne Group |Hemptown USA
For years, military veterans suffering from post-traumatic stress disorder (PTSD) have sought alternative treatments beyond traditional pharmaceuticals. Now, after years of regulatory hurdles and advocacy, the U.S. Food and Drug Administration (FDA) has approved a groundbreaking Phase 2 clinical trial to study the effects of smoked marijuana on veterans with moderate to severe PTSD.
-
Nov 7, 2024 | 
thebluntness.com | Harrison Wise |Shryne Group |Hemptown USA |Chris Faraone
In a world where public opinion often drives significant policy changes, few issues have seen a transformation as sweeping and impactful as marijuana legalization in the United States. Election night 2024 delivered a mix of victories and setbacks for cannabis reform advocates. While several initiatives succeeded at state and local levels, others faced formidable obstacles.
-
Nov 1, 2024 | 
thebluntness.com | Harrison Wise |Shryne Group |Hemptown USA |Chris Faraone
As New Yorkâs cannabis industry enters its first major growth phase, a new report from Whitney Economics highlights the potential for the market to scale to $6 billion in annual sales within the next few years. Despite nearing $1 billion in annualized sales since adult-use legalization in 2021, only 15% of New Yorkâs cannabis consumers currently buy from legal dispensaries.
-
Oct 23, 2024 | 
thebluntness.com | Harrison Wise |Shryne Group |Hemptown USA |Chris Faraone
As cannabis becomes legal in more regions across the U.S. and globally, one critical issue has come to light: the alarming increase in accidental ingestion of cannabis edibles by young children. Between 2017 and 2021, the National Poison Data System recorded over 7,000 cases of cannabis exposure among children under the age of 6, with a 1,375% spike during this period. The vast majority of these cases stemmed from edibles left within the home, often mistaken for regular candies or treats.
-
Oct 9, 2024 | 
thebluntness.com | Harrison Wise |Shryne Group |Hemptown USA |Taylor Engle
Sober October has gained traction as a month-long challenge encouraging people to go alcohol-free. Much like Dry January, it offers an opportunity to reassess drinking habits and explore alternatives to alcohol. What started as a temporary challenge is now sparking deeper lifestyle changes and a broader movement toward "sober curiosity," where individuals question their substance use and experiment with reduced or alternative consumption.
-
Oct 9, 2024 | 
thebluntness.com | Harrison Wise |Shryne Group |Hemptown USA
In a 2019 New York Magazine article, a writer noted ketamine's rise in popularity among creative circles, positioning it as a trendy party drug. Ketamine, once confined to clinical settings, was now being used recreationally as a social enhancer. However, a recent episode of the Altered States podcast, reveals a more complex reality, as casual users like "Olivia" found themselves grappling with its addictive potential.
-
Sep 24, 2024 | 
thebluntness.com | Harrison Wise |Hemptown USA |Taylor Engle |Shryne Group
As cannabis legalization continues to spread globally, the industry remains fragmented, with local and regional regulations creating a patchwork of markets and obstacles. Additionally, despite seeds being more accessible than ever, seed buyers often struggle with trust issues, uncertain payment methods, and a lack of information about the seeds they purchase.
